ASCL2
Basic information
Region (hg38): 11:2268498-2270588
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASCL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 0 | 0 |
Variants in ASCL2
This is a list of pathogenic ClinVar variants found in the ASCL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-2269769-G-C | not specified | Uncertain significance (Nov 15, 2021) | ||
11-2269863-T-C | not specified | Uncertain significance (Jun 11, 2024) | ||
11-2269920-G-A | not specified | Uncertain significance (Jul 27, 2024) | ||
11-2269935-G-T | not specified | Uncertain significance (Jul 14, 2021) | ||
11-2269962-G-C | not specified | Uncertain significance (Sep 20, 2023) | ||
11-2270068-C-G | not specified | Uncertain significance (Dec 19, 2022) | ||
11-2270096-G-T | not specified | Uncertain significance (Dec 21, 2022) | ||
11-2270101-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
11-2270105-G-C | not specified | Uncertain significance (Nov 11, 2024) | ||
11-2270184-G-C | not specified | Uncertain significance (Nov 21, 2024) | ||
11-2270196-C-G | not specified | Uncertain significance (Mar 24, 2023) | ||
11-2270199-G-A | not specified | Uncertain significance (Mar 21, 2022) | ||
11-2270228-G-T | not specified | Uncertain significance (Apr 22, 2024) | ||
11-2270256-G-C | not specified | Uncertain significance (Feb 23, 2023) | ||
11-2270272-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
11-2270281-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
11-2270284-G-T | not specified | Uncertain significance (Jul 09, 2021) | ||
11-2270302-G-T | not specified | Uncertain significance (Jul 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASCL2 | protein_coding | protein_coding | ENST00000331289 | 1 | 2458 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.346 | 0.496 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.556 | 32 | 42.2 | 0.759 | 0.00000214 | 1135 |
Missense in Polyphen | 17 | 25.991 | 0.65408 | 530 | ||
Synonymous | 1.11 | 14 | 20.4 | 0.686 | 0.00000104 | 460 |
Loss of Function | 0.710 | 0 | 0.586 | 0.00 | 2.45e-8 | 11 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: AS-C proteins are involved in the determination of the neuronal precursors in the peripheral nervous system and the central nervous system.;
Recessive Scores
- pRec
- 0.0997
Haploinsufficiency Scores
- pHI
- 0.375
- hipred
- N
- hipred_score
- 0.285
- ghis
- 0.573
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.974
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ascl2
- Phenotype
- cellular phenotype; endocrine/exocrine gland phenotype; digestive/alimentary phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;response to hypoxia;placenta development;transcription, DNA-templated;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;sensory organ development;negative regulation of Schwann cell proliferation;neuron differentiation;somatic stem cell population maintenance;positive regulation of transcription by RNA polymerase II;regulation of neurogenesis;spongiotrophoblast differentiation;spongiotrophoblast layer development
- Cellular component
- nucleus;cytoplasm;RNA polymerase II transcription factor complex
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription factor binding;protein dimerization activity;E-box binding